Regulation of Biotechnological Risks in a Multi-Level System

An Analysis of the EU Regulation of Genome Edited Plants in light of WTO Law and CETA

de

Éditeur :

Springer


Paru le : 2025-11-08



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
168,79

Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA.  Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal.  The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.
Pages
310 pages
Collection
n.c
Parution
2025-11-08
Marque
Springer
EAN papier
9783032024084
EAN PDF
9783032024091

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
31
Taille du fichier
15227 Ko
Prix
168,79 €
EAN EPUB
9783032024091

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
31
Taille du fichier
543 Ko
Prix
168,79 €

Elisabeth Anna Lümkea Andersen graduated in law from the University of Freiburg in 2018. Already during her studies, she focused on public international law and the interrelations of science and law especially in the field of German and international patent law. From 2018 to 2022, she has been a legal researcher at the Centre for Integrative Biological Signalling Studies, Cluster of Excellence, University of Freiburg. Her research focused on international and EU biotechnology law and its interactions with WTO law and CETA as well as public international law. For her PhD thesis which she realised as part of the CIBSS project, she especially focused on the regulation of genome editing techniques and its application to plants in EU law, WTO law and CETA, also examining the EU Commission's plans to adopt new regulations in this field.

Suggestions personnalisées